Lincoln Park Backs Marina Biotech
Lincoln Park Capital Fund, a Chicago-based institutional investor has committed to invest up to $15 million of equity capital in Marina Biotech, an oligonucleotide-based drug discovery and development company.
17 October 2011•4 mins read
